{
Boehringer Ingelheim KG

Companies

}
global bromhexine tablet market projected to reach 1131 million by 2032
The Global Bromhexine Tablet market is projected to grow from USD 875.5 million in 2023 to USD 1,131.7 million by 2032, with a CAGR of 3.7% from 2024 to 2032. This growth is driven by the rising prevalence of respiratory disorders and increasing demand for expectorants. Key players include Sanofi, Teva, and Boehringer Ingelheim, with market segmentation covering applications, types, and distribution channels across various regions.
openPR.com
GSK plc Aspen Pharmacare Holdings Ltd Boehringer Ingelheim KG Novartis AG Sanofi MYS IND PHL IDN HKG SGP TWN JPN THA AUS KOR CHN VNM Nidhi Bhavsar Show more
Healthcare, Market Report
08:02 14.12.2024
OptumRx favors Amgen's Amjevita over Sandoz and Boehringer biosimilars
OptumRx, the pharmacy benefit manager for UnitedHealth Group, will exclude Sandoz's Hyrimoz and Boehringer Ingelheim's Cyltezo from its 2025 US commercial formularies, favoring Amgen's Amjevita instead. Starting January 1, 2025, Humira will be classified as a tier three product, while Amjevita will be tier two.
Insights
Sandoz Group AG UnitedHealth Group Inc Boehringer Ingelheim KG Amgen Inc. USA Show more
Healthcare, Market Report
17:27 13.12.2024
Torrent Pharma Acquires Three Anti-Diabetes Brands from Boehringer Ingelheim
Torrent Pharma is enhancing its anti-diabetes portfolio by acquiring three brands from Boehringer Ingelheim, expected to finalize in March 2025. The brands—Cospiaq, Cospiaq Met, and Xilingio—contain Empagliflozin, a key treatment for type 2 diabetes, in a market projected to grow at a 25% CAGR. This move aims to improve patient access to diabetes care in India, which is anticipated to have 12.5 crore diabetes patients by 2045.
Moneycontrol
Indian Rupee Boehringer Ingelheim KG Torrent Pharmaceuticals Limited IND Aman Mehtani Show more
Healthcare, Press Release
14:23 04.12.2024
emerging venture capital hubs in europe driving innovation and growth
Venture capital is increasingly shaping Europe's innovation landscape, with regions like 'Swiss Valley' and 'Silicon Canals' emerging as key hubs. Switzerland's healthcare sector attracts significant investments, while Amsterdam fosters a diverse start-up ecosystem. As sustainability becomes a priority, VC firms are integrating ESG criteria, driving innovation in climate tech and renewable energy.
Asset Management
Swiss Franc Swedish Krona Euro United States Dollar Novo Nordisk A/S Johnson & Johnson Adyen N.V. Wetransfer B.V. Boehringer Ingelheim KG iZettle Ironwood Pharmaceuticals, Inc. Elastic N.V. Mollie Just Eat Takeaway.com N.V. Spotify Technology S.A. PayPal Holdings, Inc. NLD GBR CHE SWE Show more
TradFi, Market Report
14:08 29.11.2024
emerging venture capital hubs in europe focus on sustainability and innovation
Venture capital is increasingly shaping innovation in Europe, with regions like 'Swiss Valley' and 'Silicon Canals' emerging as key hubs. In 2024, Europe holds USD 47.2 billion in 'dry powder' for VC investments, particularly in healthcare and technology, despite facing competition and economic uncertainties. The growth of start-ups in these sectors is supported by strong academic institutions and strategic acquisitions by major companies, highlighting a vibrant landscape for future investment.
Asset Management
Swiss Franc Euro United States Dollar Swedish Krona Adyen N.V. Elastic N.V. Just Eat Takeaway.com N.V. Mollie Wetransfer B.V. Spotify Technology S.A. iZettle PayPal Holdings, Inc. Johnson & Johnson Novo Nordisk A/S Boehringer Ingelheim KG Ironwood Pharmaceuticals, Inc. NLD SWE GBR CHE USA Show more
Finance & Economy, Market Report
14:08 29.11.2024
europe's venture capital landscape drives innovation in sustainability and healthcare
Europe is emerging as a vibrant hub for venture capital, driven by a surge in sustainability and climate technology investments. Regions like 'Swiss Valley' and the 'Silicon Canals' are fostering innovation, particularly in healthcare and biotech, as established companies acquire startups to enhance their portfolios. With a growing focus on ESG criteria, the landscape is ripe for transformative breakthroughs that promise both financial returns and societal impact.
Asset Management
Euro United States Dollar Swiss Franc British Pound Sterling Novartis AG Novo Nordisk A/S Ironwood Pharmaceuticals, Inc. Hoffmann-La Roche AG Boehringer Ingelheim KG Johnson & Johnson Oatly Group AB NLD SWE GBR CHE Erasmus Elsner Michael Brunner Show more
Finance & Economy, Market Report
04:16 28.11.2024
europe's venture capital landscape drives innovation in sustainability and healthcare
Europe is emerging as a vibrant hub for venture capital, driven by a surge in sustainability and climate technology investments. Regions like 'Swiss Valley' and the 'Silicon Canals' are fostering innovation, particularly in healthcare and biotech, as established companies acquire startups to enhance their portfolios. With a growing focus on ESG criteria, the landscape is ripe for transformative breakthroughs that promise both financial returns and societal impact.
Asset Management
Euro Swiss Franc United States Dollar Novo Nordisk A/S Boehringer Ingelheim KG Novartis AG Johnson & Johnson Hoffmann-La Roche AG Oatly Group AB Ironwood Pharmaceuticals, Inc. CHE SWE NLD GBR Michael Brunner Erasmus Elsner Show more
TradFi, Market Report
04:16 28.11.2024
europe's venture capital landscape drives innovation in sustainability and healthcare
Europe is emerging as a vibrant hub for venture capital, driven by a surge in sustainability and climate technology investments. Regions like 'Swiss Valley' and the 'Silicon Canals' are fostering innovation, particularly in healthcare and biotech, as established companies acquire startups to enhance their portfolios. With a growing focus on ESG criteria, the landscape is ripe for transformative breakthroughs that promise both financial returns and societal impact.
Asset Management
Euro United States Dollar Novo Nordisk A/S Boehringer Ingelheim KG Novartis AG Johnson & Johnson Hoffmann-La Roche AG Oatly Group AB Ironwood Pharmaceuticals, Inc. GBR SWE NLD CHE Peter Pilavachi Show more
TradFi, Market Report
20:45 27.11.2024
global cmo in healthcare market analysis and future growth prospects
The global CMO in Healthcare market report provides a comprehensive analysis of market structure, growth factors, and competitive landscape, forecasting trends from 2024 to 2030. Key players include Accellent, Boehringer Ingelheim, and Catalent, with a focus on regional dynamics across North America, Europe, and Asia. The report highlights market segmentation by type and application, emphasizing the driving forces and potential restraints impacting future developments.
rock-news.at
Catalent, Inc. Boehringer Ingelheim KG Neil Thomas Show more
Healthcare, Market Report
10:03 22.11.2024
italians trust national health service but seek better support for professionals
Italians largely maintain trust in the National Health Service, with 40 million still relying on family doctors and pharmacists. However, healthcare professionals face significant challenges, including burnout and poor remuneration, which could erode this trust. Investment in both infrastructure and medical staff is crucial to ensure a resilient and inclusive healthcare system that meets the evolving needs of the population.
MF Milano Finanza
Boehringer Ingelheim KG ITA Gabriele Sepio
Healthcare, News Article
09:50 21.11.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Banking Regulations Central Bank Actions Corporate Responsibility & ESG Decentralized Finance (DeFi) Innovations Tokenomics and Crypto Economics Cryptocurrency & Blockchain Regulations Mergers & Acquisitions Cryptocurrency Developments Blockchain Technology Adoption Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Cryptocurrency Regulations Emerging Startups SEC & Financial Compliance Inflation Rates & CPI Data Banking & Investment Regulations
Countries:
USA CHE GBR DEU ARE HKG AUS JPN IND CHN CAN SGP DNK AUT LIE KOR NGA FIN COL VGB
Companies:
Credit Suisse Real Estate Fund Siat Coinbase Global, Inc. BlackRock, Inc. Solana USD Ripples USD Ethereum USD Apple Inc. Tesla, Inc. Fidelity Contrafund Cardano USD NVIDIA Corporation Grayscale Litecoin Trust Chainlink USD Tether USDt CNY Google Inc. Amazon.com, Inc. MicroStrategy Inc Franklin Templeton - Franklin M End Federal Reserve USD MicroStrategy Incorporated
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Indian Rupee Canadian Dollar Mozambican Metical British Pound Sterling Norwegian Krone Mongolian Tögrög Colombian Peso Singapore Dollar
People:
Donald Trump Ali Martinez Elon Musk Karin Keller-Sutter Jerome Powell Ueli Maurer Michael J. Saylor Gary Gensler Thomas Jordan Colm Kelleher Alan Santana Paul Atkins Joe Rogan Martin Schlegel Isabelle Chassot Mario Nawfal Paolo Ardoino Sergio Ermotti Dana White Joe Biden

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.